News Focus
News Focus
Followers 2371
Posts 118410
Boards Moderated 0
Alias Born 12/17/2011

Re: georgie18 post# 690

Tuesday, 12/10/2024 8:14:07 AM

Tuesday, December 10, 2024 8:14:07 AM

Post# of 710
CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y